← Back to Search

Technology-Enhanced Care for Depression in Cancer Patients (SCOPE-C Trial)

N/A

Recruiting

Led By Jesse R. Fann

Research Sponsored by University of Washington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 18 years or older

Participants must be ambulatory for clinical care visits

Must not have

Advanced cancer or other condition that limits remaining life expectancy to less than 9 months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial compares the effectiveness of technology-enhanced collaborative care management to usual collaborative care management in reducing depression symptoms in patients with cancer.

Who is the study for?

This trial is for adults with clinically significant depression (PHQ-9 score >=10) who are undergoing active cancer treatment and can use a smartphone, tablet, or computer. It's not for those with advanced cancer limiting life expectancy to less than 9 months or individuals needing immediate specialty mental health care.

What is being tested?

The study compares technology-enhanced collaborative care management (t-CoCM) versus usual care in managing depression for cancer patients. t-CoCM integrates tech tools to help clinicians deliver behavioral treatments and monitor patient progress more effectively.

What are the potential side effects?

Since the interventions involve non-medical treatments like interviews, focus groups, surveys, and media/technology usage rather than drugs or surgery, typical medical side effects are not expected; however, participants may experience discomfort from discussing personal issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I can walk to my clinic appointments.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My doctor expects I have less than 9 months to live due to my condition.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Adherence to guideline-level depression treatment

Change in depression severity

Level of treatment engagement (collaboration & coordination of care)

+1 more

Secondary study objectives

Care Managers experience using the new technology

Care manager (CM) satisfaction with Collaborative Care Management (CoCM) of depression

Change in Alcohol, Smoking, and Substance Use

+15 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (t-CoCM)Experimental Treatment3 Interventions

Patients use the t-CoCM digital app platform and clinic care managers use the t-CoCM web-based registry platform to support delivery of collaborative care. Patient's complete surveys at baseline, 3, 6 and 9 months. Some patients also participate in an interview or focus group about their user experience with the t-CoCM digital platform. Care managers also participate in interviews regarding their experience with CoCM and the newly developed web-based platform.

Group II: Arm II (u-CoCM)Active Control2 Interventions

Patients receive usual care and clinic care managers deliver usual CoCM. Patients complete surveys at baseline, 3, 6 and 9 months.

0 / 3Eligibility criteria met